This report provides a comprehensive analysis of the global custom plasmid production and manufacturing market, focusing on the design and production of specialized plasmid DNA for biotechnology and genetic engineering. It examines market dynamics across various grades, including research, industrial, and GMP, while highlighting key applications such as gene therapy and drug development. The study evaluates regional growth trends in the Americas, APAC, and Europe, alongside competitive strategies of major industry players.

Market Overview

The global Custom Plasmid Production and Manufacturing market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate during the forecast period.

Definition

Customized plasmid production and manufacturing refers to the design, construction, and production of plasmid DNA with specific sequences tailored to meet individual customer requirements.

Plasmids are small, circular DNA molecules commonly found in bacteria that possess the ability to replicate autonomously and be stably inherited. In the fields of biotechnology and genetic engineering, plasmids are frequently utilized as vectors to introduce exogenous genes into recipient cells for various purposes, including gene transfer, gene expression, or gene therapy.

Regional Market Analysis

United States

The United States market for Custom Plasmid Production and Manufacturing is estimated to undergo consistent growth from 2025 through 2032.

China

The China market for Custom Plasmid Production and Manufacturing is expected to see a continuous increase in market value between 2025 and 2032.

Europe

The Europe market for Custom Plasmid Production and Manufacturing is projected to expand steadily from 2025 through 2032.

Market Segmentation

By Type

• Research Grade
• Industrial Grade
• GMP Grade
• Others

By Application

• Gene Therapy
• Basic Research
• Drug Development
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• Aldevron
• Catalent Biologics
• Polyplus
• Creative Biogene
• PlasmidFactory GmbH
• Bionexus
• Wuxi Advanced Therapies
• Charles River Laboratories
• Plasmid Biosciences
• Sartorius AG
• Porton Advanced
• Oxford Genetics LTD
• uBriGene
• TriLink BioTechnologies
• Vectorbuilder

Market Share

In 2025, the global market was characterized by significant concentration, with the two largest companies collectively holding a substantial portion of the total market share.

Report Scope and Methodology

LPI (LP Information) Research Scope

The "Custom Plasmid Production and Manufacturing Industry Forecast" report by LPI (LP Information) provides a comprehensive analysis of the industry. The scope includes:

• Review of total global Custom Plasmid Production and Manufacturing sales in 2025.
• Detailed analysis of projected sales from 2026 through 2032.
• Segmentation of sales by region, market sector, and sub-sector.
• Financial analysis presented in US$ millions.

Analytical Depth

This Insight Report delivers a high-level overview of the global landscape, highlighting critical trends regarding:

• Product segmentation
• Company formation
• Revenue and market share
• Latest industry developments
• Mergers and Acquisitions (M&A) activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Custom Plasmid Production and Manufacturing portfolios, capabilities, market entry strategies, market positions, and geographic footprints to understand their unique standing in an accelerating global market.

Methodology

The study evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down the forecast by Type, Application, Geography, and Market Size to identify emerging opportunities. The forecast utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the current state and future trajectory of the industry.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Custom Plasmid Production and Manufacturing Market Size (2021-2032)

    • 2.1.2 Custom Plasmid Production and Manufacturing Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Custom Plasmid Production and Manufacturing by Country/Region (2021, 2025 & 2032)

  • 2.2 Custom Plasmid Production and Manufacturing Segment by Type

    • 2.2.1 Research Grade

    • 2.2.2 Industrial Grade

    • 2.2.3 GMP Grade

    • 2.2.4 Others

    • 2.2.5 Custom Plasmid Production and Manufacturing Market Size by Type

      • 2.2.5.1 Custom Plasmid Production and Manufacturing Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global Custom Plasmid Production and Manufacturing Market Size Market Share by Type (2021-2026)

  • 2.3 Custom Plasmid Production and Manufacturing Segment by Application

    • 2.3.1 Gene Therapy

    • 2.3.2 Basic Research

    • 2.3.3 Drug Development

    • 2.3.4 Others

    • 2.3.5 Custom Plasmid Production and Manufacturing Market Size by Application

      • 2.3.5.1 Custom Plasmid Production and Manufacturing Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Custom Plasmid Production and Manufacturing Market Size Market Share by Application (2021-2026)

• 3 Custom Plasmid Production and Manufacturing Market Size by Player

  • 3.1 Custom Plasmid Production and Manufacturing Market Size Market Share by Player

    • 3.1.1 Global Custom Plasmid Production and Manufacturing Revenue by Player (2021-2026)

    • 3.1.2 Global Custom Plasmid Production and Manufacturing Revenue Market Share by Player (2021-2026)

  • 3.2 Global Custom Plasmid Production and Manufacturing Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Custom Plasmid Production and Manufacturing by Region

  • 4.1 Custom Plasmid Production and Manufacturing Market Size by Region (2021-2026)

  • 4.2 Global Custom Plasmid Production and Manufacturing Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Custom Plasmid Production and Manufacturing Market Size Growth (2021-2026)

  • 4.4 APAC Custom Plasmid Production and Manufacturing Market Size Growth (2021-2026)

  • 4.5 Europe Custom Plasmid Production and Manufacturing Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Custom Plasmid Production and Manufacturing Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Custom Plasmid Production and Manufacturing Market Size by Country (2021-2026)

  • 5.2 Americas Custom Plasmid Production and Manufacturing Market Size by Type (2021-2026)

  • 5.3 Americas Custom Plasmid Production and Manufacturing Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Custom Plasmid Production and Manufacturing Market Size by Region (2021-2026)

  • 6.2 APAC Custom Plasmid Production and Manufacturing Market Size by Type (2021-2026)

  • 6.3 APAC Custom Plasmid Production and Manufacturing Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Custom Plasmid Production and Manufacturing Market Size by Country (2021-2026)

  • 7.2 Europe Custom Plasmid Production and Manufacturing Market Size by Type (2021-2026)

  • 7.3 Europe Custom Plasmid Production and Manufacturing Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Custom Plasmid Production and Manufacturing by Region (2021-2026)

  • 8.2 Middle East & Africa Custom Plasmid Production and Manufacturing Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Custom Plasmid Production and Manufacturing Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Custom Plasmid Production and Manufacturing Market Forecast

  • 10.1 Global Custom Plasmid Production and Manufacturing Forecast by Region (2027-2032)

    • 10.1.1 Global Custom Plasmid Production and Manufacturing Forecast by Region (2027-2032)

    • 10.1.2 Americas Custom Plasmid Production and Manufacturing Forecast

    • 10.1.3 APAC Custom Plasmid Production and Manufacturing Forecast

    • 10.1.4 Europe Custom Plasmid Production and Manufacturing Forecast

    • 10.1.5 Middle East & Africa Custom Plasmid Production and Manufacturing Forecast

  • 10.2 Americas Custom Plasmid Production and Manufacturing Forecast by Country (2027-2032)

    • 10.2.1 United States Market Custom Plasmid Production and Manufacturing Forecast

    • 10.2.2 Canada Market Custom Plasmid Production and Manufacturing Forecast

    • 10.2.3 Mexico Market Custom Plasmid Production and Manufacturing Forecast

    • 10.2.4 Brazil Market Custom Plasmid Production and Manufacturing Forecast

  • 10.3 APAC Custom Plasmid Production and Manufacturing Forecast by Region (2027-2032)

    • 10.3.1 China Custom Plasmid Production and Manufacturing Market Forecast

    • 10.3.2 Japan Market Custom Plasmid Production and Manufacturing Forecast

    • 10.3.3 Korea Market Custom Plasmid Production and Manufacturing Forecast

    • 10.3.4 Southeast Asia Market Custom Plasmid Production and Manufacturing Forecast

    • 10.3.5 India Market Custom Plasmid Production and Manufacturing Forecast

    • 10.3.6 Australia Market Custom Plasmid Production and Manufacturing Forecast

  • 10.4 Europe Custom Plasmid Production and Manufacturing Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Custom Plasmid Production and Manufacturing Forecast

    • 10.4.2 France Market Custom Plasmid Production and Manufacturing Forecast

    • 10.4.3 UK Market Custom Plasmid Production and Manufacturing Forecast

    • 10.4.4 Italy Market Custom Plasmid Production and Manufacturing Forecast

    • 10.4.5 Russia Market Custom Plasmid Production and Manufacturing Forecast

  • 10.5 Middle East & Africa Custom Plasmid Production and Manufacturing Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Custom Plasmid Production and Manufacturing Forecast

    • 10.5.2 South Africa Market Custom Plasmid Production and Manufacturing Forecast

    • 10.5.3 Israel Market Custom Plasmid Production and Manufacturing Forecast

    • 10.5.4 Turkey Market Custom Plasmid Production and Manufacturing Forecast

  • 10.6 Global Custom Plasmid Production and Manufacturing Forecast by Type (2027-2032)

  • 10.7 Global Custom Plasmid Production and Manufacturing Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Custom Plasmid Production and Manufacturing Forecast

• 11 Key Players Analysis

  • 11.1 Aldevron

    • 11.1.1 Aldevron Company Information

    • 11.1.2 Aldevron Custom Plasmid Production and Manufacturing Product Offered

    • 11.1.3 Aldevron Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Aldevron Main Business Overview

    • 11.1.5 Aldevron Latest Developments

  • 11.2 Catalent Biologics

    • 11.2.1 Catalent Biologics Company Information

    • 11.2.2 Catalent Biologics Custom Plasmid Production and Manufacturing Product Offered

    • 11.2.3 Catalent Biologics Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Catalent Biologics Main Business Overview

    • 11.2.5 Catalent Biologics Latest Developments

  • 11.3 Polyplus

    • 11.3.1 Polyplus Company Information

    • 11.3.2 Polyplus Custom Plasmid Production and Manufacturing Product Offered

    • 11.3.3 Polyplus Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Polyplus Main Business Overview

    • 11.3.5 Polyplus Latest Developments

  • 11.4 Creative Biogene

    • 11.4.1 Creative Biogene Company Information

    • 11.4.2 Creative Biogene Custom Plasmid Production and Manufacturing Product Offered

    • 11.4.3 Creative Biogene Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Creative Biogene Main Business Overview

    • 11.4.5 Creative Biogene Latest Developments

  • 11.5 PlasmidFactory GmbH

    • 11.5.1 PlasmidFactory GmbH Company Information

    • 11.5.2 PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Product Offered

    • 11.5.3 PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 PlasmidFactory GmbH Main Business Overview

    • 11.5.5 PlasmidFactory GmbH Latest Developments

  • 11.6 Bionexus

    • 11.6.1 Bionexus Company Information

    • 11.6.2 Bionexus Custom Plasmid Production and Manufacturing Product Offered

    • 11.6.3 Bionexus Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Bionexus Main Business Overview

    • 11.6.5 Bionexus Latest Developments

  • 11.7 Wuxi Advanced Therapies

    • 11.7.1 Wuxi Advanced Therapies Company Information

    • 11.7.2 Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Product Offered

    • 11.7.3 Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Wuxi Advanced Therapies Main Business Overview

    • 11.7.5 Wuxi Advanced Therapies Latest Developments

  • 11.8 Charles River Laboratories

    • 11.8.1 Charles River Laboratories Company Information

    • 11.8.2 Charles River Laboratories Custom Plasmid Production and Manufacturing Product Offered

    • 11.8.3 Charles River Laboratories Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Charles River Laboratories Main Business Overview

    • 11.8.5 Charles River Laboratories Latest Developments

  • 11.9 Plasmid Biosciences

    • 11.9.1 Plasmid Biosciences Company Information

    • 11.9.2 Plasmid Biosciences Custom Plasmid Production and Manufacturing Product Offered

    • 11.9.3 Plasmid Biosciences Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Plasmid Biosciences Main Business Overview

    • 11.9.5 Plasmid Biosciences Latest Developments

  • 11.10 Sartorius AG

    • 11.10.1 Sartorius AG Company Information

    • 11.10.2 Sartorius AG Custom Plasmid Production and Manufacturing Product Offered

    • 11.10.3 Sartorius AG Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Sartorius AG Main Business Overview

    • 11.10.5 Sartorius AG Latest Developments

  • 11.11 Porton Advanced

    • 11.11.1 Porton Advanced Company Information

    • 11.11.2 Porton Advanced Custom Plasmid Production and Manufacturing Product Offered

    • 11.11.3 Porton Advanced Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Porton Advanced Main Business Overview

    • 11.11.5 Porton Advanced Latest Developments

  • 11.12 Oxford Genetics LTD

    • 11.12.1 Oxford Genetics LTD Company Information

    • 11.12.2 Oxford Genetics LTD Custom Plasmid Production and Manufacturing Product Offered

    • 11.12.3 Oxford Genetics LTD Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Oxford Genetics LTD Main Business Overview

    • 11.12.5 Oxford Genetics LTD Latest Developments

  • 11.13 uBriGene

    • 11.13.1 uBriGene Company Information

    • 11.13.2 uBriGene Custom Plasmid Production and Manufacturing Product Offered

    • 11.13.3 uBriGene Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 uBriGene Main Business Overview

    • 11.13.5 uBriGene Latest Developments

  • 11.14 TriLink BioTechnologies

    • 11.14.1 TriLink BioTechnologies Company Information

    • 11.14.2 TriLink BioTechnologies Custom Plasmid Production and Manufacturing Product Offered

    • 11.14.3 TriLink BioTechnologies Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 TriLink BioTechnologies Main Business Overview

    • 11.14.5 TriLink BioTechnologies Latest Developments

  • 11.15 Vectorbuilder

    • 11.15.1 Vectorbuilder Company Information

    • 11.15.2 Vectorbuilder Custom Plasmid Production and Manufacturing Product Offered

    • 11.15.3 Vectorbuilder Custom Plasmid Production and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Vectorbuilder Main Business Overview

    • 11.15.5 Vectorbuilder Latest Developments

• 12 Research Findings and Conclusion